Celsius (NASDAQ:CELH) Receives “Equal Weight” Rating from Morgan Stanley

Morgan Stanley restated their equal weight rating on shares of Celsius (NASDAQ:CELH) in a research report report published on Tuesday, Benzinga reports. They currently have a $68.00 price objective on the stock.

CELH has been the topic of several other research reports. Maxim Group decreased their target price on Celsius from $110.00 to $90.00 and set a buy rating on the stock in a research report on Tuesday, June 18th. Stifel Nicolaus decreased their price objective on Celsius from $95.00 to $85.00 and set a buy rating on the stock in a report on Wednesday, June 12th. Jefferies Financial Group dropped their target price on Celsius from $104.00 to $98.00 and set a buy rating for the company in a report on Thursday, June 13th. Piper Sandler upped their price target on shares of Celsius from $76.00 to $90.00 and gave the company an overweight rating in a research note on Friday, March 1st. Finally, Truist Financial assumed coverage on shares of Celsius in a research report on Tuesday. They set a hold rating and a $60.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of Moderate Buy and an average target price of $83.16.

Celsius Price Performance

Shares of Celsius stock opened at $55.86 on Tuesday. Celsius has a 1 year low of $45.03 and a 1 year high of $99.62. The company has a market capitalization of $13.02 billion, a price-to-earnings ratio of 61.38, a P/E/G ratio of 1.80 and a beta of 1.93. The business has a fifty day simple moving average of $75.77 and a two-hundred day simple moving average of $70.17.

Celsius (NASDAQ:CELH) last posted its earnings results on Tuesday, May 7th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.07. Celsius had a net margin of 18.63% and a return on equity of 111.29%. The company had revenue of $355.70 million during the quarter, compared to analysts’ expectations of $390.37 million. During the same quarter last year, the company posted $0.13 EPS. Celsius’s quarterly revenue was up 36.9% compared to the same quarter last year. As a group, equities analysts anticipate that Celsius will post 1.07 earnings per share for the current fiscal year.

Insider Activity at Celsius

In other Celsius news, CFO Jarrod Langhans sold 4,079 shares of the company’s stock in a transaction on Friday, April 19th. The stock was sold at an average price of $69.42, for a total transaction of $283,164.18. Following the completion of the sale, the chief financial officer now directly owns 83,670 shares in the company, valued at $5,808,371.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CFO Jarrod Langhans sold 4,079 shares of the business’s stock in a transaction on Friday, April 19th. The stock was sold at an average price of $69.42, for a total transaction of $283,164.18. Following the completion of the transaction, the chief financial officer now owns 83,670 shares of the company’s stock, valued at approximately $5,808,371.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, major shareholder William H. Milmoe sold 40,000 shares of the company’s stock in a transaction on Friday, May 17th. The stock was sold at an average price of $92.95, for a total value of $3,718,000.00. Following the sale, the insider now owns 226,245 shares of the company’s stock, valued at $21,029,472.75. The disclosure for this sale can be found here. Insiders have sold 1,776,696 shares of company stock valued at $107,920,209 over the last three months. 2.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Celsius

A number of institutional investors have recently added to or reduced their stakes in CELH. Vanguard Group Inc. boosted its position in Celsius by 18.7% in the first quarter. Vanguard Group Inc. now owns 16,313,762 shares of the company’s stock valued at $1,352,737,000 after buying an additional 2,567,290 shares in the last quarter. Capital International Investors lifted its stake in shares of Celsius by 50.6% in the 1st quarter. Capital International Investors now owns 3,966,194 shares of the company’s stock valued at $328,877,000 after acquiring an additional 1,333,217 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of Celsius by 212.2% during the 4th quarter. Wellington Management Group LLP now owns 3,393,586 shares of the company’s stock valued at $185,018,000 after acquiring an additional 2,306,598 shares in the last quarter. Eagle Asset Management Inc. grew its position in Celsius by 188.8% during the 4th quarter. Eagle Asset Management Inc. now owns 2,958,771 shares of the company’s stock worth $161,312,000 after acquiring an additional 1,934,400 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in Celsius by 0.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,802,264 shares of the company’s stock worth $232,365,000 after purchasing an additional 9,054 shares in the last quarter. 60.95% of the stock is currently owned by institutional investors and hedge funds.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.